Edwards Lifesciences expands litigation against CoreValve to US
This article was originally published in Clinica
Executive Summary
The patent row between Edwards Lifesciences and CoreValve has expanded into the US, after Irvine, California-based Edwards filed a suit against its rival in a district court in Delaware. Edwards kicked off the legal dispute in May 2007 by initiating a lawsuit against CoreValve in Germany, and shortly after in the UK. The row centres around a group of patents owned by Edwards, known as the Andersen patents, which relates to transcatheter heart valve technology. Edwards alleges that CoreValve's ReValving system, which is designed to replace heart valves in a minimally-invasive manner, infringes these patents and is seeking injunctive relief and damages.
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.
Novartis Nominates Ex-BMS Chief As It Pursues US Growth Strategy
The Swiss pharma company is looking to tap into the experience of ex-BMS leader Giovanni Caforio to help further it US-first commercial strategy.